Beta cell response to a mixed meal in nigerian patients with type 2 diabetes

BMC Endocrine Disorders

Chioma N Unachukwu²  Sonny Chinenye¹  Ekenechukwu E Young¹ 

[1] Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria;Department of Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

关键词: Glycaemic control;    Meal stimulation;    Type2 diabetes;    Beta cell;   

Others  :  1086386
DOI  :  10.1186/1472-6823-12-11

 received in 2012-02-09, accepted in 2012-06-27,  发布年份 2012

【 摘 要 】

Background

The pathophysiology of type2 diabetes involves both insulin resistance and poor beta cell function. Studies have been done in several populations to assess the relative importance of these mechanisms in individual patients. In our environment studies to assess beta cell function have been done with glucagon stimulation or an oral glucose tolerance test. This study was done to assess the response of the beta cell to a standardized mixed meal and its relationship with glycaemic control in patients with type2 diabetes.

Methods

Ninety patients with type 2 diabetes were recruited into the study. Weight, height, body mass index and waist circumference were measured. Blood samples were analysed for fasting plasma glucose (FPG) and fasting C peptide (FCP) and glycated haemoglobin (HbA1c). Patients were given their usual drugs for management of their diabetes and then served with a standard meal calculated to contain 50 g of carbohydrate, made up of 53 % carbohydrate, 17 % of protein and 30 % of lipids, providing 500 kcal. Blood samples 2 hours after the start of the meal were analysed for postprandial glucose (PPG) and postprandial C peptide (PCP). Fasting (M0) and postprandial beta cell responsiveness (M1) were calculated.

Results

The mean FPG and PPG were 7.51+/− 3.39 mmol/l and 11.02+/−4.03 mmol/l respectively while the mean glycated haemoglobin (HbA1c) was 9.0+/−2.5 %. The mean fasting C peptide was 1.44+/−1.80ug/ml. Many of the patients (56.7 %) had low FCP levels. The mean postprandial C peptide was 4.0+/−2.8 ng/ml. There were significant correlations between M1, HbA1c and PPG (p = 0.015, 0.024, 0.001 respectively) and also between M0, HbA1c, PPG and FPG (p = 0.001, 0.002, 0.001). HbA1c decreased across increasing tertiles of M0 (p < 0.001) and also M1 (p = 0.002). In step-wise linear regression analysis, M0 and M1 significantly predicted HbA1c.

Conclusions

Many of the patients had low C peptide levels with poor beta cell response to the meal. The patients had poor glycaemic control and poor beta cell function. Both fasting and postprandial beta cell responsiveness were significant determinants of blood glucose and glycated haemoglobin levels. It is likely that putting these patients on insulin may have led to better glycaemic control in them.

【 授权许可】

   
2012 Young et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Gerich JE: The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity. Endocr Rev 1998, 19:491-503.
• [2]Prospective UK Diabetes Study Group: Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years therapy of type 2 diabetes: a progressive disease. Diabetes 1995, 44:1248-58.
• [3]Kahn SE: The importance of the beta cell in the pathogenesis of type 2 Diabetes Mellitus. Am J Med 2000, 108:2-8.
• [4]Pratley R, Weyer C: The role of impaired early insulin secretion in the pathogenesis of type 2 diabetes mellitus. Diabetologia 2001, 44:929-945.
• [5]Porte D Jr: Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of Type2 Diabetes and its complications. Diab Metab Res Rev. 2001, 17:181-188.
• [6]Cobelli C, Toffolo GM, Man CD, et al.: Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007, 293:E1-E15.
• [7]Albarrak AI, Luzio SD, Chassin LJ, et al.: Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes. JCEM 2002, 87(1):198-203.
• [8]Osei K, Gaillard T, Schuster DP: Pathogenic mechanisms of impaired glucose tolerance and type2 diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity and glucose effectiveness. Diabetes Care 1997, 20:396-404.
• [9]Bakari AG, Onyemelukwe GC: Plasma insulin response to oral glucose tolerance test in Nigerian type2 diabetics. East Afr Med J. 2004, 81:463-467.
• [10]Joffe BI, Panz VR, Wing JR, et al.: Pathogenesis of non-insulin-dependent diabetes in the Black population of Southern Africa. Lancet 1992, 340:460-462.
• [11]Oli JM, Adeyemo AA, Okafor GO, et al.: Beta cell function and response to treatment in Nigerians with Type 2 diabetes mellitus. Diab Res Clin Pract. 2005, 69:196-204.
• [12]Hovorka R, Chassin L, Luzio SD: Pancreatic β-Cell Responsiveness during Meal Tolerance Test: Model assessment in normal subjects and subjects with newly diagnosed Noninsulin-Dependent Diabetes Mellitus. JCEM 1998, 83:744-750.
• [13]Shim WS, Kim KS, Kang ES, et al.: Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes. Eur J Endocrinol 2006, 155:615-622.